PHGDH-IN-3
PHGDH-IN-3 is an orally active phosphoglycerate dehydrogenase (PHGDH) inhibitor. PHGDH-IN-3 inhibits PHGDH with an IC50 value of 2.8 μM. PHGDH-IN-3 can be used for the research of cancer[1].
Product Specifications
CAS Number
2893778-31-7
UNSPSC
12352005
Target
Phosphoglycerate Dehydrogenase (PHGDH)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/phgdh-in-3.html
Purity
99.34
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 70°C)
Smiles
CC(C1=CC=CC(NS(=O)(C2=CC=C(C=C2)C(NC3=NC(C4=CC=CC(F)=C4)=CS3)=O)=O)=C1)=O
Molecular Formula
C24H18FN3O4S2
Molecular Weight
495.55
References & Citations
[1]Dingding Gao, et al. Discovery of Novel Drug-like PHGDH Inhibitors to Disrupt Serine Biosynthesis for Cancer Therapy. J Med Chem. 2023 Jan 12;66 (1) :285-305.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
27984141 1x 10^6 Cells / 1.0 mL
MAN1B1 CRISPR Knock Out 293T Cell Line (Human)
Sign In for Pricing
View Details 
GTR15205031 1 Vial
Lentiviral mouse Cd69 shRNA (UAS) - Lentiviral mouse Cd69 shRNA (UAS, RFP) (25)
Sign In for Pricing
View Details